Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Ahmed F. Salem, Gloria Bonuccelli, Generoso Bevilacqua, Hwyda Arafat, Richard G. Pestell, Federica Sotgia & Michael P. Lisanti. (2011) Caveolin-1 promotes pancreatic cancer cell differentiation and restores membranous E-cadherin via suppression of the epithelial-mesenchymal transition. Cell Cycle 10:21, pages 3692-3700.
Read now
Read now
Articles from other publishers (7)
Wang Kai, Shan Yating, Ma Lin, Yang Kaiyong, Hua Baojin, Yin Wu, Yin Fangzhou & Chen Yan. (2018) Natural product toosendanin reverses the resistance of human breast cancer cells to adriamycin as a novel PI3K inhibitor. Biochemical Pharmacology 152, pages 153-164.
Crossref
Crossref
Hiroaki Kinoh, Yutaka Miura, Tsukasa Chida, Xueying Liu, Kazue Mizuno, Shigeto Fukushima, Yosuke Morodomi, Nobuhiro Nishiyama, Horacio Cabral & Kazunori Kataoka. (2016)
Nanomedicines Eradicating Cancer Stem-like Cells
in Vivo
by pH-Triggered Intracellular Cooperative Action of Loaded Drugs
. ACS Nano 10:6, pages 5643-5655.
Crossref
Crossref
Andrea Turner, Liang-Cheng Li, Tania Pilli, Lixia Qian, Elizabeth Louise Wiley, Suman Setty, Konstantin Christov, Lakshmy Ganesh, Ajay V. Maker, Peifeng Li, Prasad Kanteti, Tapas K. Das Gupta & Bellur S. Prabhakar. (2013) MADD Knock-Down Enhances Doxorubicin and TRAIL Induced Apoptosis in Breast Cancer Cells. PLoS ONE 8:2, pages e56817.
Crossref
Crossref
Yeon A. Choi, Jeong Su Park, Mi Young Park, Ki Sook Oh, Myung Sok Lee, Jong-Seok Lim, Keun Il Kim, Kun-yong Kim, Junhye Kwon, Do Young Yoon, Eun-Yi Moon & Young Yang. (2011) Increase in CIP2A expression is associated with doxorubicin resistance. FEBS Letters 585:5, pages 755-760.
Crossref
Crossref
Ying Qu, Jinhua Wang, Myung-Shin Sim, Bingya Liu, Armando Giuliano, James Barsoum & Xiaojiang Cui. (2009) Elesclomol, counteracted by Akt survival signaling, enhances the apoptotic effect of chemotherapy drugs in breast cancer cells. Breast Cancer Research and Treatment 121:2, pages 311-321.
Crossref
Crossref
Song Li, Yunfei Zhou, Ruiwen Wang, Haitao Zhang, Yan Dong & Clement Ip. (2007) Selenium sensitizes MCF-7 breast cancer cells to doxorubicin-induced apoptosis through modulation of phospho-Akt and its downstream substrates. Molecular Cancer Therapeutics 6:3, pages 1031-1038.
Crossref
Crossref
Xinqun Li, Yang Lu, Ke Liang, Bolin Liu & Zhen Fan. (2005) Differential responses to doxorubicin-induced phosphorylation and activation of Akt in human breast cancer cells. Breast Cancer Research 7:5.
Crossref
Crossref